AOD-9604
Support fat metabolism without affecting blood sugar.
For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.
About AOD-9604
AOD-9604 is a modified fragment (176-191) of human growth hormone designed to mimic hGH's lipolytic (fat-burning) action without effects on blood sugar or growth. It stimulates lipolysis in animal and cell studies. Crucially, human trials did not confirm meaningful weight loss: a 12-week study showed only a small effect that was not dose-dependent, and larger clinical development for obesity was discontinued after it failed to beat placebo. It is not an approved weight-loss agent.
Key Benefits
- Stimulates fat breakdown in animal/cell studies
- Does not affect blood sugar or IGF-1
- Human obesity trials did NOT show meaningful weight loss
- Clinical development for obesity was discontinued
Set a goal (top of the page) to see how AOD-9604 scores against it, and what the better-evidenced alternatives are.
Category Ratings
How to Take
Common Side Effects
- Injection site swelling
- Headache
- Mild nausea
- Indigestion
Legal & Regulatory Status
Research use only. Not FDA-approved. Human obesity trials did not demonstrate meaningful weight loss.
Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.
Research & Sources
Sources are selected for reliability (peer-reviewed literature, openFDA, ClinicalTrials.gov) but this is a research summary, not medical advice, and may not be exhaustive.
